Genome-wide association study and functional follow-up identify 14q12 as a candidate risk locus for cervical cancer.
Female
Follow-Up Studies
Forkhead Transcription Factors
/ genetics
Genetic Predisposition to Disease
Genome-Wide Association Study
Humans
Nerve Tissue Proteins
/ genetics
Papillomaviridae
/ genetics
Papillomavirus Infections
/ complications
Polymorphism, Single Nucleotide
/ genetics
Uterine Cervical Neoplasms
/ genetics
Journal
Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958
Informations de publication
Date de publication:
17 08 2022
17 08 2022
Historique:
received:
28
07
2021
revised:
21
01
2022
accepted:
24
01
2022
pubmed:
15
2
2022
medline:
25
8
2022
entrez:
14
2
2022
Statut:
ppublish
Résumé
Cervical cancer is among the leading causes of cancer-related death in females worldwide. Infection by human papillomavirus (HPV) is an established risk factor for cancer development. However, genetic factors contributing to disease risk remain largely unknown. We report on a genome-wide association study (GWAS) on 375 German cervical cancer patients and 866 healthy controls, followed by a replication study comprising 658 patients with invasive cervical cancer, 1361 with cervical dysplasia and 841 healthy controls. Functional validation was performed for the top GWAS variant on chromosome 14q12 (rs225902, close to PRKD1). After bioinformatic annotation and in silico predictions, we performed transcript analysis in a cervical tissue series of 317 samples and demonstrate rs225902 as an expression quantitative trait locus (eQTL) for FOXG1 and two tightly co-regulated long non-coding RNAs at this genomic region, CTD-2251F13 (lnc-PRKD1-1) and CTD-2503I6 (lnc-FOXG1-6). We also show allele-specific effects of the 14q12 variants via luciferase assays. We propose a combined effect of genotype, HPV status and gene expression at this locus on cervical cancer progression. Taken together, this work uncovers a potential candidate locus with regulatory functions and contributes to the understanding of genetic susceptibility to cervical cancer.
Identifiants
pubmed: 35157032
pii: 6528272
doi: 10.1093/hmg/ddac031
pmc: PMC9396939
doi:
Substances chimiques
FOXG1 protein, human
0
Forkhead Transcription Factors
0
Nerve Tissue Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2483-2497Informations de copyright
© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Références
Hered Cancer Clin Pract. 2004 May 15;2(2):99-105
pubmed: 20233477
Trends Genet. 2015 Jan;31(1):41-54
pubmed: 25467628
PLoS One. 2008;3(10):e3392
pubmed: 18852890
Oncotarget. 2016 Jul 5;7(27):42216-42224
pubmed: 27285765
Mol Cancer. 2016 May 27;15(1):43
pubmed: 27233618
J Med Virol. 2014 Jul;86(7):1153-8
pubmed: 24700089
J Biol Chem. 2005 Apr 8;280(14):13205-8
pubmed: 15701647
Am J Hum Genet. 2018 May 3;102(5):717-730
pubmed: 29727686
Am J Hum Genet. 2013 Nov 7;93(5):779-97
pubmed: 24210251
PLoS Genet. 2017 Aug 14;13(8):e1006866
pubmed: 28806749
Cell. 2012 May 11;149(4):819-31
pubmed: 22541069
Int J Gynecol Pathol. 2020 May;39(3):279-288
pubmed: 31206367
Carcinogenesis. 2015 Sep;36(9):992-8
pubmed: 26045304
Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):126-135
pubmed: 27697780
Int J Cancer. 2020 Nov 1;147(9):2458-2468
pubmed: 32580243
Oncotarget. 2017 May 26;8(40):67203-67217
pubmed: 28978027
Papillomavirus Res. 2019 Jun;7:132-134
pubmed: 30954690
Int J Cancer. 2019 Aug 15;145(4):1033-1041
pubmed: 30895602
Elife. 2018 May 30;7:
pubmed: 29846171
Nat Genet. 2013 Aug;45(8):918-22
pubmed: 23817570
Nature. 2017 Mar 16;543(7645):378-384
pubmed: 28112728
Hum Mol Genet. 2019 Jan 15;28(2):341-348
pubmed: 30412241
Clin Genet. 2018 Mar;93(3):520-532
pubmed: 29194587
Cancer Epidemiol Biomarkers Prev. 1998 Oct;7(10):865-8
pubmed: 9796630
Nature. 2007 Jun 7;447(7145):661-78
pubmed: 17554300
Int J Cancer. 2021 Apr 27;:
pubmed: 33905146
Nat Genet. 2011 Jun;43(6):513-8
pubmed: 21614091
Lancet Oncol. 2021 Apr;22(4):548-557
pubmed: 33794208
Int J Cancer. 2000 Dec 1;88(5):698-701
pubmed: 11072236
Biomed Pharmacother. 2016 Apr;79:294-301
pubmed: 27044840
Nat Commun. 2020 Sep 4;11(1):4423
pubmed: 32887889
Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):283-294
pubmed: 28577984
Nat Genet. 2006 Aug;38(8):904-9
pubmed: 16862161
Cancer Res. 2015 Sep 15;75(18):3728-37
pubmed: 26208906
J Natl Cancer Inst. 2013 May 1;105(9):624-33
pubmed: 23482656
Cancers (Basel). 2021 Oct 13;13(20):
pubmed: 34680286
Facts Views Vis Obgyn. 2018 Jun;10(2):107-113
pubmed: 31110650
Nature. 2017 Nov 2;551(7678):92-94
pubmed: 29059683
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Sci Rep. 2017 Jan 25;7:41103
pubmed: 28120872
Cancers (Basel). 2021 Sep 10;13(18):
pubmed: 34572780
PLoS One. 2011 May 12;6(5):e19416
pubmed: 21589913